Hot Features
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism ... Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.07 | -10 | 0.7 | 0.71 | 0.63 | 81045 | 0.68665185 | DE |
| 4 | -0.105 | -14.2857142857 | 0.735 | 0.88 | 0.63 | 62772 | 0.75205156 | DE |
| 12 | -0.14 | -18.1818181818 | 0.77 | 0.88 | 0.63 | 49700 | 0.75387562 | DE |
| 26 | -0.27 | -30 | 0.9 | 1.29 | 0.63 | 64787 | 0.84762239 | DE |
| 52 | -0.53 | -45.6896551724 | 1.16 | 1.29 | 0.56 | 70626 | 0.85271859 | DE |
| 156 | -1.29 | -67.1875 | 1.92 | 3.15 | 0.56 | 56013 | 1.38443856 | DE |
| 260 | -2.08 | -76.7527675277 | 2.71 | 3.15 | 0.56 | 43823 | 1.44211549 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.